Astrana Health ASTH Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $429.47M+48.9% | $288.46M-1.9% | $294.15M+2.1% | $288.03M+23.6% | ||
| $26.26M+4.1% | $25.24M+44.6% | $17.45M+17.9% | $14.8M-20.6% | ||
| $26.22M+64.5% | $15.94M0.0% | $15.94M0.0% | $15.94M0.0% | ||
| $863.31M+35.2% | $638.5M+38.4% | $461.51M+7.8% | $428.13M+5.9% | ||
| $57.33M+302% | $14.27M+99.1% | $7.17M-93.4% | $108.54M+104% | ||
| $35.74M+9.6% | $32.6M-12.8% | $37.4M+82.9% | $20.44M+32.4% | ||
| $865.31M+106% | $419.25M+50.4% | $278.83M+3.6% | $269.05M+9.2% | ||
| $270.97M+129% | $118.18M+64.9% | $71.65M-6.8% | $76.86M-7.2% | ||
| $48.72M-5.0% | $51.27M+93.7% | $26.47M— | $0-100% | ||
| $25.64M-34.8% | $39.32M+52.6% | $25.77M-36.0% | $40.3M-3.4% | ||
| $1.36B+89.2% | $716.4M+51.8% | $471.85M-12.3% | $538.09M+16.2% | ||
| $2.22B+63.8% | $1.35B+45.2% | $933.36M-3.4% | $966.21M+11.4% | ||
| $195.91M+84.6% | $106.14M+77.1% | $59.95M+21.0% | $49.56M+12.8% | ||
| $24.46M-11.0% | $27.48M+45.1% | $18.94M— | $0— | ||
| $47.87M+411% | $9.38M-51.9% | $19.5M+3,050% | $619K-20.6% | ||
| $7.81M+46.0% | $5.35M+16.1% | $4.61M+29.0% | $3.57M+35.9% | ||
| $615.27M+68.3% | $365.61M+67.2% | $218.67M+47.1% | $148.61M+29.5% | ||
| $990.9M+133% | $425.3M+64.2% | $258.94M+27.3% | $203.39M+11.2% | ||
| $31.55M+2.9% | $30.65M-15.5% | $36.29M+82.2% | $19.92M+50.9% | ||
| $39.36M+9.3% | $36M-12.0% | $40.9M+74.1% | $23.49M+48.4% | ||
| $17.11M+17.1% | $14.61M+307% | $3.59M-82.3% | $20.26M+37.1% | ||
| $335.71M+60.6% | $209.04M+96.0% | $106.66M+31.3% | $81.26M+45.7% | ||
| $1.05B+120% | $475.12M+56.3% | $303.92M+17.3% | $259.06M+7.0% | ||
| $1.66B+97.5% | $840.73M+60.9% | $522.59M+28.2% | $407.67M+14.3% | ||
| $0— | $0— | —— | —— | ||
| $49K+2.1% | $48K+2.1% | $47K0.0% | $47K+4.4% | ||
| $470.86M+10.4% | $426.39M+14.9% | $371.04M+3.0% | $360.1M+15.8% | ||
| $308.38M+7.7% | $286.28M+17.7% | $243.13M+33.3% | $182.42M+32.9% | ||
| $14.01M+250% | $4.01M+64.7% | $2.43M+39.1% | $1.75M-70.6% | ||
| $779.29M+9.3% | $712.72M+16.0% | $614.22M+13.2% | $542.56M+21.1% | ||
| $2.22B+63.8% | $1.35B+45.2% | $933.36M-3.4% | $966.21M+11.4% | ||
| $26.39M-10.5% | $29.5M+2,109% | $1.34M-27.2% | $1.83M-81.0% | ||
| $4.93M— | $0— | —— | $996K— | ||
| $26.39M-10.5% | $29.5M+2,109% | $1.34M-27.2% | $1.83M-81.0% | ||
| $25.42M+52.5% | $16.67M+788% | $1.88M-58.8% | $4.56M-23.1% | ||
| $48.72M-5.0% | $51.27M+93.7% | $26.47M— | $0-100% | ||
| $35.74M+9.6% | $32.6M-12.8% | $37.4M+82.9% | $20.44M+32.4% | ||
| $270.97M+129% | $118.18M+64.9% | $71.65M-6.8% | $76.86M-7.2% | ||
| $48.72M-5.0% | $51.27M+93.7% | $26.47M— | $0-100% | ||
| $35.74M+9.6% | $32.6M-12.8% | $37.4M+82.9% | $20.44M+32.4% | ||
| $25.42M+52.5% | $16.67M+788% | $1.88M-58.8% | $4.56M-23.1% | ||
| $35.74M+9.6% | $32.6M-12.8% | $37.4M+82.9% | $20.44M+32.4% | ||
| $25.42M+52.5% | $16.67M+788% | $1.88M-58.8% | $4.56M-23.1% | ||
| $195.91M+84.6% | $106.14M+77.1% | $59.95M+21.0% | $49.56M+12.8% | ||
| $3.52M-57.1% | $8.22M+6.3% | $7.74M-4.1% | $8.07M— | ||
| $335.71M+60.6% | $209.04M+96.0% | $106.66M+31.3% | $81.26M+45.7% | ||
| $24.46M-11.0% | $27.48M+45.1% | $18.94M— | $0— | ||
| $1.08B+128% | $471.84M+47.0% | $321.01M+40.0% | $229.36M+14.1% | ||
| $49K+2.1% | $48K+2.1% | $47K0.0% | $47K+4.4% | ||
| $0— | $0— | —— | —— | ||
| $5.49M+20.5% | $4.56M+11.9% | $4.07M-71.4% | $14.22M-52.8% | ||
| $25.64M-34.8% | $39.32M+52.6% | $25.77M-36.0% | $40.3M-3.4% | ||
| $1.8M-90.7% | $19.32M+81.3% | $10.66M— | $0— | ||
| $26.22M+64.5% | $15.94M0.0% | $15.94M0.0% | $15.94M0.0% | ||
| $14.01M+250% | $4.01M+64.7% | $2.43M+39.1% | $1.75M-70.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Astrana Health cover its short-term obligations?
- Its current ratio is 1.35 — current assets exceed current liabilities.
- Where does Astrana Health's balance sheet data come from?
- Every line is extracted from Astrana Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.